P45 - ECE_2394 - Hypertension in adrenal insufficiency: prevalence, disease specific factors and insights into regulation of the renin-angiotensin-aldosterone system
Aug 2026· European Journal of Endocrinology· Vol 195· 0 citations
TL;DR
While classical risk factors appear dominant, the observed associations with GC replacement and cortisol profiles indicate unphysiological steroid exposure under conventional treatment contributes to BP elevations.
Abstract
Retrospective analyses consistently show higher cardiovascular (CV) mortality and morbidity in patients with adrenal insufficiency (AI) compared to controls. However, factors driving the increased CV risk remain poorly understood.
Assess the prevalence of hypertension (HT) by 24-hour blood pressure (24h-BP) measurements and associations with disease-related parameters in patients from our multicentric AI registry.
We measured 24h-BP in 281 patients (71% primary AI (PAI), 68% female, mean age 50 ± 14 years, 24% under antihypertensive treatment). HT was diagnosed according to ESC/ESH thresholds. Results were correlated with hormone replacement regimens, salivary- and urinary cortisol, key effectors of the renin-angiotensin-aldosterone system (RAAS) (Angiotensin I/II, Aldosterone, angiotensin-converting-enzyme activity (ACE-Q)) and routine clinical and biochemical parameters.
24h-BP was elevated in 59% of all patients (PAI 57% vs SAI 74%, P = .006) and in 52% of patients without antihypertensive treatment (PAI 52% vs SAI 53%, P = 0.88). Nighttime-HT was more prevalent than daytime-HT (48% vs 38%) regardless of antihypertensive therapy and 33% of the cohort were non-dippers. Logistic regression in patients not receiving antihypertensive therapy showed significant associations of male sex, BMI, and renal function with 24h-HT, and of higher glucocorticoid (GC) doses with daytime-HT. In the subgroup with available RAAS data, evening GC intake and ACE-Q were additionally associated with 24h-HT and nighttime-HT. Linear regression in patients with 24h-HT demonstrated associations between mean systolic BP and higher 24h urinary cortisol, salivary cortisol AUC, and GC replacement dose.
Nighttime hypertension and non-dipping are frequent in our cohort. While classical risk factors appear dominant, the observed associations with GC replacement and cortisol profiles indicate unphysiological steroid exposure under conventional treatment contributes to BP elevations.
Introduction: Fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis and is associated with cardiovascular-kidney-metabolic syndrome in patients with chronic kidney disease in part mediated by angiotensin II. X-linked hypophosphatemia (XLH) is characterized by phosphate wasting due to excess FGF23 activity...
Sivaram Kumareswaran, Jossiell Cortes, A. South· Research Square· 0 citations
Aldosterone dysregulation is common in patients with essential hypertension and is associated with suboptimal blood pressure control, and currently available treatments may not fully address aldosterone dysregulation.
Javed Butler, K. Hammonds, Muhammad Sameer Arshad et al.· American Journal of Cardiolo...· 0 citations
BACKGROUND
Adrenal-related biomarkers are central in evaluating endocrine causes of secondary hypertension, but their interpretation is influenced by biological variation (BV). In this study, we aimed to estimate the within-subject (CVI) and between-subject (CVG) BV and derive the reference change values (RCVs), the In...
Anna Stylianou Lerpold, R. Chowdhury, E. Røys et al.· Clinical Chemistry· 0 citations
Introduction To characterize electrolyte and renal-metabolic profiles in primary aldosteronism (PA) compared with essential hypertension (EH), and to examine differences between unilateral/lateralizing and bilateral PA. Methods PubMed, Embase, the Cochrane Library, and Web of Science were searched from inception throug...
Xuan Zhao, Cai-Yan Zhang, Chun-Xiu Yi et al.· Frontiers in Endocrinology· 0 citations
Hypercortisolism and type 2 diabetes mellitus (T2D) independently contribute to an increased burden of cardiometabolic morbidity and mortality. However, data on the interaction of hypercortisolism and T2D are scarce—thus, we aimed to assess the cortisol-associated morbidity and mortality in the context of T2D and adren...
Luise Bellach, S. Hofer-Zeni, Dorota Sluková et al.· Cardiovascular Diabetology· 0 citations
Purpose We aimed to assess whether low-grade albuminuria, characterized by a low urinary albumin-to-creatinine ratio (UACR) within the normal range (<30 mg/g), could predict cardiovascular disease (CVD) risk in a low-risk general population, with an emphasis on sex- and menopause-specific differences. Materials and Met...
Minjeong Ko, Y. Jeong, J. Kim et al.· Yonsei medical journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.